Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP)
NCT04474444 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55000
Last updated 2024-12-11
Summary
The Primary objective is to explore ambulance service attendance at incidents involving alcohol and/or substance use over the period of the pandemic lockdown, and the following months. This will be to determine prevalence and explore factors such as patient gender, age, ethnicity or location. Analysis will examine the calls over the course of the year prior to the lockdown, and then compare this to the period of lockdown and following months.
Conditions
- Alcohol Use, Unspecified
- Substance Use
- Intoxication Alcohol
- Emergencies
- COVID-19 Pandemic
- Treatment
Interventions
- OTHER
-
attendance by ambulance crew
hear, attendance, convey
Sponsors & Collaborators
-
University of Lincoln
lead OTHER
Principal Investigators
-
Graham Law, PhD · University of Lincoln
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-03-23
- Primary Completion
- 2021-03-23
- Completion
- 2021-03-23
Countries
- United Kingdom
Study Locations
More Related Trials
-
W-SUDs for COVID-19
NCT04460027 ·Status: COMPLETED ·Phase: PHASE1
-
Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use
NCT05191446 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
NCT02299921 ·Status: RECRUITING
-
Assertive Community Treatment for Alcohol Misuse Disorder Patients Who Are High Utilizers of Emergency Department Services
NCT04447079 ·Status: NOT_YET_RECRUITING
-
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
NCT01519063 ·Status: COMPLETED ·Phase: PHASE2
-
Emergency Department-Initiated Medications for Alcohol Use Disorder
NCT05827159 ·Status: RECRUITING ·Phase: PHASE3
-
The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion
NCT00667771 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effectiveness of a Smartphone Application in the Treatment of Alcohol Use Disorder
NCT03396887 ·Status: UNKNOWN ·Phase: NA
-
ED Initiated Oral Naltrexone for AUD
NCT04817410 ·Status: COMPLETED ·Phase: PHASE1
-
CBD for the Treatment of Alcohol Use Disorder
NCT04873453 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT04931095 ·Status: COMPLETED ·Phase: PHASE1
-
Alcohol Disorder hOsPital Treatment Trial
NCT02478489 ·Status: COMPLETED ·Phase: PHASE4
-
Inpatient Single Dose Interventions for Alcohol Use Disorder
NCT04562779 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Novel Human Lab Model for Screening AUD Medications
NCT04249882 ·Status: COMPLETED ·Phase: PHASE2
-
Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder
NCT04094584 ·Status: TERMINATED ·Phase: PHASE4
-
Consequences of At-risk Alcohol Consumption in ICU Patients
NCT03565016 ·Status: COMPLETED
-
An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
NCT02842073 ·Status: COMPLETED ·Phase: PHASE2
-
Naltrexone, Craving, and Drinking
NCT00006203 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence
NCT02382276 ·Status: COMPLETED ·Phase: PHASE3
-
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT06293040 ·Status: RECRUITING ·Phase: PHASE1
-
Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger
NCT02579317 ·Status: COMPLETED ·Phase: NA
-
Naltrexone Effects on Alcohol Intake
NCT00254670 ·Status: COMPLETED ·Phase: NA
-
Impulsivity Domains and Subjective Response
NCT05929677 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Will Having Alcohol Treatment Improve Functioning?
NCT01245647 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of TripleA for Treatment of Alcohol Addiction in Outpatient Care
NCT03195894 ·Status: COMPLETED ·Phase: NA